Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REPLIGEN CORP | Senior VP, R&D | Common Stock | 12.3K | $1.95M | $158.85 | Aug 2, 2024 | Direct |
REPLIGEN CORP | Senior VP, R&D | Stock Option (Right to Buy) | 0 | Aug 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Aug 2, 2024 | 4 | -$1.12M | 4 | Aug 5, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Aug 1, 2024 | 1 | -$740K | 4 | Aug 1, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | May 14, 2024 | 1 | -$87.2K | 4 | May 15, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Mar 11, 2024 | 3 | -$572K | 4 | Mar 12, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Mar 7, 2024 | 1 | -$75.5K | 4 | Mar 7, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Mar 4, 2024 | 1 | -$26.2K | 4 | Mar 6, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 29, 2024 | 2 | -$86.9K | 4 | Mar 4, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 27, 2024 | 2 | $0 | 4 | Feb 29, 2024 | Senior VP, R&D |
RGEN | REPLIGEN CORP | May 16, 2023 | 1 | -$109K | 4 | May 16, 2023 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Mar 2, 2023 | 4 | -$234K | 4 | Mar 6, 2023 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 28, 2023 | 1 | -$62K | 4 | Mar 1, 2023 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 28, 2023 | 1 | -$79.4K | 4 | Feb 28, 2023 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Aug 11, 2022 | 8 | -$1.03M | 4 | Aug 12, 2022 | Senior VP, R&D |
RGEN | REPLIGEN CORP | May 13, 2022 | 1 | -$107K | 4 | May 17, 2022 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 27, 2022 | 4 | -$498K | 4 | Mar 2, 2022 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 24, 2022 | 3 | -$35.6K | 4 | Feb 28, 2022 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Feb 17, 2022 | 2 | -$31.9K | 4 | Feb 22, 2022 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Dec 14, 2021 | 1 | -$112K | 4 | Dec 15, 2021 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Aug 30, 2021 | 1 | -$1.13M | 4 | Sep 2, 2021 | Senior VP, R&D |
RGEN | REPLIGEN CORP | Jun 10, 2021 | 5 | -$1.04M | 4 | Jun 14, 2021 | Senior VP, R&D |
RGEN | REPLIGEN CORP | May 14, 2021 | 1 | -$122K | 4 | May 18, 2021 | Senior VP, R&D |